GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Youngevity International Inc (OTCPK:YGYI) » Definitions » EBITDA

Youngevity International (Youngevity International) EBITDA : $-41.9 Mil (TTM As of Sep. 2020)


View and export this data going back to 2009. Start your Free Trial

What is Youngevity International EBITDA?

Youngevity International's EBITDA for the three months ended in Sep. 2020 was $-3.3 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was $-41.9 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Youngevity International's EBITDA per Share for the three months ended in Sep. 2020 was $-0.10. Its EBITDA per share for the trailing twelve months (TTM) ended in Sep. 2020 was $-1.37.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Youngevity International EBITDA Historical Data

The historical data trend for Youngevity International's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Youngevity International EBITDA Chart

Youngevity International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EBITDA
Get a 7-Day Free Trial 7.52 7.75 0.17 -8.37 -44.63

Youngevity International Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.03 -32.02 -3.90 -2.62 -3.33

Competitive Comparison of Youngevity International's EBITDA

For the Packaged Foods subindustry, Youngevity International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Youngevity International's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Youngevity International's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Youngevity International's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Youngevity International's EBITDA for the fiscal year that ended in Dec. 2019 is calculated as

Youngevity International's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2019, Youngevity International's EBITDA was $-44.6 Mil.

Youngevity International's EBITDA for the quarter that ended in Sep. 2020 is calculated as

Youngevity International's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Sep. 2020, Youngevity International's EBITDA was $-3.3 Mil.

EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-41.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Youngevity International  (OTCPK:YGYI) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Youngevity International EBITDA Related Terms

Thank you for viewing the detailed overview of Youngevity International's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Youngevity International (Youngevity International) Business Description

Traded in Other Exchanges
N/A
Address
2400 Boswell Road, Chula Vista, CA, USA, 91914
Youngevity International Inc offers nutritional products and commercial coffee. The company operates in three segments, the Direct Selling segment which generates the majority of its revenue, the commercial hemp segment and the Commercial Coffee segment. Its product portfolio includes nutritional supplements, sports and energy drinks, health and wellness, lifestyle products, gourmet coffee, and skincare and cosmetics.
Executives
Paul Sallwasser director C/O ELYS GAME TECHNOLOGY CORP., 130 ADELAIDE STREET WEST, SUITE 701, TORONTO A6 M5H2K4
Richard Renton director C/O AL INTERNATIONAL, INC., 2400 BOSWELL ROAD, CHULA VISTA CA 91914
Michelle Wallach director, 10 percent owner, officer: CHIEF OPERATING OFFICER C/O AL INTERNATIONAL, INC., 2400 BOSWELL ROAD, CHULA VISTA CA 91914
Stephan Wallach director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER C/O AL INTERNATIONAL, INC., 2400 BOSWELL ROAD, CHULA VISTA CA 91914
David Briskie director, officer: PRESIDENT AND CFO C/O AL INTERNATIONAL, INC., 2400 BOSWELL ROAD, CHULA VISTA CA 91914
William G Thompson director C/O AL INTERNATIONAL, INC., 2400 BOSWELL ROAD, CHULA VISTA CA 91914
Kevin B Allodi director C/O YOUNGEVITY INTERNATIONAL, INC., 2400 BOSWELL ROAD, CHULA VISTA CA 91914
William Andreoli officer: PRESIDENT C/O AL INTERNATIONAL, INC., 2400 BOSWELL ROAD, CHULA VISTA CA 91914
John P Rochon director 2400 NORTH DALLAS PARKWAY, PLANO TX 75093

Youngevity International (Youngevity International) Headlines

From GuruFocus